DUBLIN--(BUSINESS WIRE)--The "Genotyping - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
Genotyping market worldwide is projected to grow by US$34.9 Billion, guided by a compounded growth of 22.1%
Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments. Polymerase Chain Reaction (PCR), one of the segments analyzed and sized in this study, displays the potential to grow at over 21.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market.
Poised to reach over US$14.5 Billion by the year 2025, Polymerase Chain Reaction (PCR) will bring in healthy gains adding significant momentum to global growth.
While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 26.8% growth momentum.
Within Europe, which continues to remain an important element in the world economy, Germany will add over US$2.8 Billion to the region's size and clout in the next 5 to 6 years. Over US$2.1 Billion worth of projected demand in the region will come from other emerging Eastern European markets.
In Japan, Polymerase Chain Reaction (PCR) will reach a market size of US$941.6 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 20.4% over the next couple of years and add approximately US$5.5 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.
Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include
- Affymetrix, Inc. (USA)
- Agilent Technologies, Inc. (USA)
- Beckman Coulter, Inc. (USA)
- Fluidigm Corporation (USA)
- GE Healthcare (USA)
- Illumina, Inc. (USA)
- Life Technologies Corporation (USA)
- Qiagen NV (The Netherlands)
- Roche Diagnostics (USA)
- Sequenom, Inc. (USA)
For more information about this report visit https://www.researchandmarkets.com/r/w7agzh